Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
2 Start an online visit Tell us about you and your health goals so your provider can personalize your care
As of early 2026, injectable GHK-Cu returned to 503A compounding availability in the US following regulatory reclassification
Key facts: First studied by researchers at the University of Zagreb (Croatia) in the early 1990s Over 100 peer-reviewed studies published since then (Kang et al., 2021) Administered via subcutaneous injection (most common), intramuscular injection, or orally Typical research dosages: 200-800 mcg per day Classification: Research peptide, not approved by the FDA for human use How it works (simplified): BPC-157 appears to promote healing by improving blood flow to damaged tissue, reducing inflammation, and supporting the body's natural repair processes
The recipes looked great
US$ 23.66
US$ 29.63
US$ 28.09
US$ 28.16
US$ 26.26
US$ 22.28
